GlassScriptPhysician profile
Lindsay E Elton
NPI 1013119130
$8,315.81
in general payments reported to CMS, 2019-2025
55 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 76% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,653 · 2020: $735 · 2021: $770 · 2022: $1,198 · 2023: $982 · 2024: $1,338 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,943 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,943.04 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $865.90 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Sk Life Science, INC. | $712.95 | 2022-2025 | |
| Corium, LLC | $622.75 | 2021-2025 | Azstarys |
| Aquestive Therapeutics, INC. | $560.46 | 2019-2025 | |
| Tris Pharma INC | $488.61 | 2019-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $431.98 | 2019-2025 | Qelbree, Qelbree |
| Sunovion Pharmaceuticals INC. | $429.55 | 2019-2022 | |
| Greenwich Biosciences, INC. | $419.58 | 2019-2020 | |
| Livanova USA, INC. | $376.69 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neos Therapeutics, LP | $317.28 | 2019-2025 | Cotempla Xr-Odt |
| Vertical Pharmaceuticals, LLC | $262.37 | 2019-2025 | Relexxii |
| Octapharma USA, INC. | $261.40 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Takeda Pharmaceuticals U.S.A., INC. | $231.56 | 2019-2022 | |
| Neurelis, INC. | $204.40 | 2020-2025 | Valtoco |
| Ironshore Pharmaceuticals INC. | $201.20 | 2019-2024 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Elton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.